NCT06454968
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Marginal Zone Lymphoma
Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
115 public trials
42 recruiting studies
Marginal Zone Lymphoma trial results
Recruiting
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma
NCT05846750
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tian, China
Not yet recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
Not yet recruiting
Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
NCT07609446
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Not yet recruiting
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
NCT07583810
- Conditions
- Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Extranodal Marginal Zone Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not yet recruiting
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
NCT05923502
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
- Locations
-
Not specified
Enrolling by invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States
Active, not recruiting
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
NCT05783596
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Mount Sinai Medical Center New York, United States
Active, not recruiting
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
NCT05100862
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Ucsf Fresno University of California San Francisco Fresno Fresno, California, United States
- Kaiser Permanente Southern California Irvine, California, United States
- Cancer and Blood Specialty Clinic Los Alamitos, California, United States
- Los Angeles Cancer Network Los Angeles, California, United States
Active, not recruiting
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
NCT04542824
- Conditions
- Chronic Disease, Diffuse Large B Cell Lymphoma, Disease Attributes, +25 more
- Locations
-
- Tohoku University Hoaspital Sendai, Miyagi, Japan
- Aichi Cancer Center Hospital Aichi, Japan
- NHO Nagoya Medical Center Aichi, Japan
- National Cancer Center Hospital East Chiba, Japan